vs

Side-by-side financial comparison of INTELLINETICS, INC. (INLX) and Lakeside Holding Ltd (LSH). Click either name above to swap in a different company.

Lakeside Holding Ltd is the larger business by last-quarter revenue ($7.0M vs $4.3M, roughly 1.6× INTELLINETICS, INC.). INTELLINETICS, INC. runs the higher net margin — -4.8% vs -22.6%, a 17.8% gap on every dollar of revenue. On growth, Lakeside Holding Ltd posted the faster year-over-year revenue change (95.0% vs 1.0%).

Lakeside Press was a Chicago publishing imprint under which the RR Donnelley Company produced fine books as well as mail order catalogs, telephone directories, encyclopedias, and advertising. The Press was best known for its high quality editions for the Chicago Caxton Club as well as the Lakeside Classics, a series of fine reprints.

INLX vs LSH — Head-to-Head

Bigger by revenue
LSH
LSH
1.6× larger
LSH
$7.0M
$4.3M
INLX
Growing faster (revenue YoY)
LSH
LSH
+94.0% gap
LSH
95.0%
1.0%
INLX
Higher net margin
INLX
INLX
17.8% more per $
INLX
-4.8%
-22.6%
LSH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
INLX
INLX
LSH
LSH
Revenue
$4.3M
$7.0M
Net Profit
$-208.0K
$-1.6M
Gross Margin
64.5%
27.2%
Operating Margin
-5.0%
-21.3%
Net Margin
-4.8%
-22.6%
Revenue YoY
1.0%
95.0%
Net Profit YoY
-287.3%
18.7%
EPS (diluted)
$-0.06
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INLX
INLX
LSH
LSH
Q4 25
$4.3M
$7.0M
Q3 25
$4.0M
$6.1M
Q2 25
$4.0M
$6.3M
Q1 25
$4.2M
$3.8M
Q4 24
$4.3M
$3.6M
Q3 24
$4.6M
$4.1M
Q2 24
$4.6M
Q1 24
$4.5M
Net Profit
INLX
INLX
LSH
LSH
Q4 25
$-208.0K
$-1.6M
Q3 25
$-369.8K
$-1.4M
Q2 25
$-567.6K
$-893.1K
Q1 25
$-727.6K
$-1.1M
Q4 24
$-53.7K
$-1.9M
Q3 24
$-392.9K
$-1.3M
Q2 24
$75.0K
Q1 24
$-174.7K
Gross Margin
INLX
INLX
LSH
LSH
Q4 25
64.5%
27.2%
Q3 25
64.2%
18.2%
Q2 25
68.0%
26.7%
Q1 25
67.6%
18.8%
Q4 24
63.5%
-1.2%
Q3 24
59.8%
12.8%
Q2 24
64.7%
Q1 24
64.3%
Operating Margin
INLX
INLX
LSH
LSH
Q4 25
-5.0%
-21.3%
Q3 25
-9.5%
-20.8%
Q2 25
-12.7%
-8.9%
Q1 25
-16.1%
-28.2%
Q4 24
-0.3%
-55.6%
Q3 24
-6.5%
-32.5%
Q2 24
3.7%
Q1 24
-0.8%
Net Margin
INLX
INLX
LSH
LSH
Q4 25
-4.8%
-22.6%
Q3 25
-9.2%
-22.2%
Q2 25
-14.2%
-14.2%
Q1 25
-17.1%
-28.2%
Q4 24
-1.3%
-54.1%
Q3 24
-8.6%
-32.7%
Q2 24
1.6%
Q1 24
-3.9%
EPS (diluted)
INLX
INLX
LSH
LSH
Q4 25
$-0.06
$-0.08
Q3 25
$-0.08
$-0.09
Q2 25
$-0.13
$-0.11
Q1 25
$-0.17
$-0.14
Q4 24
$-0.02
$-0.26
Q3 24
$-0.09
$-0.18
Q2 24
$0.02
Q1 24
$-0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INLX
INLX
LSH
LSH
Cash + ST InvestmentsLiquidity on hand
$1.6M
Total DebtLower is stronger
$2.4M
Stockholders' EquityBook value
$11.4M
$12.2M
Total Assets
$17.3M
$24.3M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INLX
INLX
LSH
LSH
Q4 25
$1.6M
Q3 25
$4.5M
Q2 25
$2.1M
$5.0M
Q1 25
$2.1M
$1.5M
Q4 24
$2.5M
$1.1M
Q3 24
$2.5M
$2.7M
Q2 24
$1.7M
Q1 24
$1.2M
Total Debt
INLX
INLX
LSH
LSH
Q4 25
$2.4M
Q3 25
$2.4M
Q2 25
$1.4M
Q1 25
$774.2K
Q4 24
$784.8K
Q3 24
$589.9K
Q2 24
Q1 24
Stockholders' Equity
INLX
INLX
LSH
LSH
Q4 25
$11.4M
$12.2M
Q3 25
$11.4M
$7.0M
Q2 25
$11.6M
$2.8M
Q1 25
$10.4M
$749.8K
Q4 24
$10.6M
$1.6M
Q3 24
$10.4M
$3.6M
Q2 24
$10.3M
Q1 24
$10.0M
Total Assets
INLX
INLX
LSH
LSH
Q4 25
$17.3M
$24.3M
Q3 25
$18.0M
$18.6M
Q2 25
$17.2M
$14.4M
Q1 25
$18.0M
$9.9M
Q4 24
$18.6M
$9.8M
Q3 24
$19.0M
$10.8M
Q2 24
$18.9M
Q1 24
$18.9M
Debt / Equity
INLX
INLX
LSH
LSH
Q4 25
0.20×
Q3 25
0.35×
Q2 25
0.48×
Q1 25
1.03×
Q4 24
0.48×
Q3 24
0.16×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INLX
INLX
LSH
LSH
Operating Cash FlowLast quarter
$-529.8K
$-453.5K
Free Cash FlowOCF − Capex
$-550.4K
FCF MarginFCF / Revenue
-12.7%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$579.5K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INLX
INLX
LSH
LSH
Q4 25
$-529.8K
$-453.5K
Q3 25
$1.4M
$-4.0M
Q2 25
$222.9K
$-483.7K
Q1 25
$-110.4K
$-238.3K
Q4 24
$136.2K
$-530.2K
Q3 24
$1.9M
$-1.4M
Q2 24
$1.2M
Q1 24
$611.8K
Free Cash Flow
INLX
INLX
LSH
LSH
Q4 25
$-550.4K
Q3 25
$1.3M
Q2 25
$81.2K
$-497.4K
Q1 25
$-231.4K
Q4 24
$90.0K
$-560.5K
Q3 24
$1.7M
$-1.4M
Q2 24
$994.2K
Q1 24
$593.5K
FCF Margin
INLX
INLX
LSH
LSH
Q4 25
-12.7%
Q3 25
32.0%
Q2 25
2.0%
-7.9%
Q1 25
-5.4%
Q4 24
2.1%
-15.6%
Q3 24
37.9%
-34.5%
Q2 24
21.4%
Q1 24
13.2%
Capex Intensity
INLX
INLX
LSH
LSH
Q4 25
0.5%
Q3 25
1.8%
Q2 25
3.5%
0.2%
Q1 25
2.9%
0.0%
Q4 24
1.1%
0.8%
Q3 24
4.2%
0.1%
Q2 24
3.9%
Q1 24
0.4%
Cash Conversion
INLX
INLX
LSH
LSH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
15.68×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INLX
INLX

Segment breakdown not available.

LSH
LSH

Transferred Over Time$4.6M65%
Distribution Of Pharmaceutical Products$2.4M35%

Related Comparisons